Table 2.
Incidence of Primary and Secondary End Points in G+ and G− Patients
| End Point | All Patients (n=100) | Child Patients | Adult Patients | ||||
|---|---|---|---|---|---|---|---|
| G+ (n=6) | G− (n=11) | P Value | G+ (n=32) | G− (n=51) | P Value | ||
| Primary | |||||||
| Death and heart transplantation | 32 (32.0) | 2 (33.3) | 2 (18.2) | 0.584 | 16 (50.0) | 12 (23.5) | 0.013 |
| Secondary | |||||||
| All‐cause death | 27 (27.0) | 1 (16.7) | 2 (18.2) | 1.000 | 12 (37.5) | 12 (23.5) | 0.172 |
| Heart transplantation | 5 (5.0) | 1 (16.7) | 0 (0.0) | 0.353 | 4 (12.5) | 0 (0.0) | 0.020 |
| Cardiovascular death | 27 (27.0) | 1 (16.7) | 2 (18.2) | 1.000 | 12 (37.5) | 12 (23.5) | 0.172 |
| Sudden cardiac death | 6 (6.0) | 0 (0.0) | 2 (18.2) | 0.515 | 1 (3.1) | 3 (5.9) | 1.000 |
| Heart failure–related death | 20 (20.0) | 1 (16.7) | 0 (0.0) | 0.353 | 11 (34.4) | 8 (15.7) | 0.049 |
Data are given as number (percentage). G+ indicates genotype positive; G−, genotype negative.